Fuse Science, Inc. (DROP) Financial Statements (2024 and earlier)

Company Profile

Business Address 5510 MERRICK RD.
MASSAPEQUA, NY 11758
State of Incorp. NV
Fiscal Year End September 30
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2015
MRQ
9/30/2014
9/30/2013
9/30/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 02962
Cash and cash equivalents 02962
Receivables  4330
Inventory, net of allowances, customer advances and progress billings  1,337142
Inventory  1,337142
Prepaid expense  15
Prepaid expense and other current assets340
Other undisclosed current assets 6  
Total current assets: 61,424574
Noncurrent Assets
Property, plant and equipment 614394
Intangible assets, net (including goodwill)  7982
Intangible assets, net (excluding goodwill)  7982
Prepaid expense and other noncurrent assets50
Total noncurrent assets: 6222226
TOTAL ASSETS: 121,646800
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,0811,8761,080
Accounts payable 1,0811,695792
Accrued liabilities  181288
Debt 20179110
Derivative instruments and hedges, liabilities  252 
Other undisclosed current liabilities  (252)(5)
Total current liabilities: 1,1012,0551,185
Noncurrent Liabilities
Long-term debt and lease obligation   86
Long-term debt, excluding current maturities   86
Liabilities, other than long-term debt 1,213  
Derivative instruments and hedges, liabilities 1,213  
Other undisclosed noncurrent liabilities  252 
Total noncurrent liabilities: 1,21325286
Total liabilities: 2,3142,3071,270
Equity
Equity, attributable to parent (2,176)(535)(344)
Common stock 2277165
Additional paid in capital 50,00043,67022,605
Accumulated deficit (52,178)(44,482)(23,114)
Equity, attributable to noncontrolling interest (126)(126)(126)
Total equity: (2,302)(661)(471)
TOTAL LIABILITIES AND EQUITY: 121,646800

Income Statement (P&L) ($ in thousands)

6/30/2015
TTM
9/30/2014
9/30/2013
9/30/2012
Revenues 44931174
Revenue, net 449487105
Cost of revenue
(Cost of Goods and Services Sold)
  (176) 
Other undisclosed gross profit (1,425)  
Gross profit: (976)13574
Operating expenses (4,465)(9,161)(7,917)
Other undisclosed operating income  176422
Operating loss: (5,441)(8,850)(7,421)
Nonoperating expense (2,259)(12,518)(3,621)
Debt instrument, convertible, beneficial conversion feature   (822)
Interest and debt expense (196)(2,968)(2,981)
Loss from continuing operations before income taxes: (7,896)(24,336)(14,023)
Income tax expense (2,617) (3,754)
Loss from continuing operations: (10,513)(24,336)(17,777)
Loss before gain (loss) on sale of properties: (10,513)(24,336)(17,777)
Other undisclosed net income 2,8182,9686,735
Net loss available to common stockholders, diluted: (7,696)(21,368)(11,042)

Comprehensive Income ($ in thousands)

6/30/2015
TTM
9/30/2014
9/30/2013
9/30/2012
Net loss: (7,696)(21,368)(11,042)
Comprehensive loss, net of tax, attributable to parent: (7,696)(21,368)(11,042)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: